SEC Form 4 · accession 0001683168-18-000658
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Miller
Officer — Chief Financial Officer
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par vlue per shareF1 | Mar 9, 2018 | P | 1,200 | $3.90 | A | 15,268 | I | See Note |
| Common Stock, $0.0001 par vlue per shareF1 | Mar 12, 2018 | P | 1,200 | $4.03 | A | 16,468 | I | See Note |
| Common Stock, $0.0001 par vlue per share | holding | — | — | — | 20,088 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are owned by Mr. Miller as trustee for The Miller 2005 Grandchildren's Trust, for which Mr. Miller and his wife, Margaret I. Miller, are the trustees.